Trial intelligence / Profile preview

Ticagrelor vs Clopidogrel in American Indian Patients with Stable CAD

NCT01706510Phase 4Completed

Sponsor
Monument Health Rapid City Hospital
Start
Dec 2012
Primary completion
Mar 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ticagrelor in coronary artery disease (CAD), sponsored by Monument Health Rapid City Hospital. Started Dec 2012; status: completed.

02

Drugs

ticagrelor
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT01706510.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01706510.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call